期刊文献+

从监管科学角度浅谈化妆品行业监管的法制化保障 被引量:1

Discussion on legalization of the cosmetic industry regulatory from the perspective of regulatory science
原文传递
导出
摘要 化妆品是人们日常生活不可或缺的消费品。我国化妆品行业的市场规模居世界第二,但产品同质化严重且质量良莠不齐,行业整体水平有待提高,市场违法违规行为层出不穷。因此,公职人员以政策法规为准绳对行业进行监管,践行依法行政和科学监管,才能激发市场的主体活力,助推行业高质量发展。从化妆品监管科学、宏观政策、主要法规、监管组织等方面汇总了行业监管法制化保障的重要依据与抓手,以期通过粗浅的评析能对化妆品从业者起到抛砖引玉的作用。 Cosmetics are indispensable consumer goods in people's daily life.At present,China has become the second largest cosmetics consumption market in the world,yet,product homogeneity is serious and the quality is mixed,the overall level of the industry needs to be improved,illegal market behaviors emerge in endlessly.Therefore,only supervising the industry according to policies and regulations,and practicing law-based administration and scientific supervision,can we stimulate the vitality of the main body of the market and promote the high quality development of the industry.Summarized the legal important basis and grasp of cosmetic industry regulatory from the aspects of the cosmetic regulatory science,policy,chief legal system and supervision organization,hoping that it can play a valuable role for cosmetic practitioners through superficial analysis.
作者 舒航 朱冰 赵扬 Shu Hang;Zhu Bing;Zhao Yang(Henan Technical Institute,Zhengzhou 450042,China)
出处 《中国卫生法制》 2023年第3期35-39,58,共6页 China Health Law
基金 2022年度河南省高校人文社会科学研究一般项目“中国特色法规建设助力化妆品行业安全监管制度的研究”(2022-ZDJH-00142) 河南应用技术职业学院2022年度校级立项科研项目“基于创业胜任力提升的高职创业教育研究——以化妆品经营与管理专业为例”(2022-SK-YB-46) 河南应用技术职业学院青年骨干教师资助项目(2022-GGJS-H007)。
关键词 监管科学 化妆品监管 法制化 Regulatory science Cosmetics regulation Legalization
  • 相关文献

参考文献12

二级参考文献47

  • 1许伟,蓝翁驰.药械组合产品的监管对策探讨[J].中国医疗器械信息,2009,15(8):50-52. 被引量:8
  • 2田一芳.新加坡健康科学局监管经验介绍[J].上海食品药品监管情报研究,2012(6):1-2. 被引量:1
  • 3焦家泉.独具特色的药物管制——新加坡药品宏观管理简介[J].中国卫生经济,1995,14(6):62-63. 被引量:5
  • 4中国食品药品检定研究院.中检院关于征集科学检验精神课题的通知[EB/OL].http://www.niepbp.org.cn/CL0014/3726.html,[2012-08-07].
  • 5Chieko Kurihara. Takeo Saio what is the regulation sci- ence? Concept and history in the United States and in Japan interview with professor Sheila Hasanoff [J]. Clin Eval,2011, 39 (1): 1-16.
  • 6U. S. Food and Drug Administration. Advancing regulato- ry seience [EB/OL]. [2014-02-25]. http: //www. fda. gov / scienceresearch/ spccialtopics/ regu|atorysciencc/ defau|t. htm.
  • 7Welnberg AM. Science and trans-science [J]. Science, 1972, 177 (4045): 211-212.
  • 8Uchiyama M. Prospect for drug product quality: regulatory consideration [J]. Pharmaceutical Technology, 1996, 20 (10): 44-52.
  • 9Harvard Kennedy School. SheilaJasanoff [EB/OL]. [2014- 02 25 ] http, //www. hks. harvard, edu/about/faculty-staff- directory/sheila-jasanoff.
  • 10Jasanoff S. The fifth branch science advisers as policymaker [M]. London: Harvard University Press, 1990.

共引文献77

同被引文献33

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部